Ironwood ends gout drug deal with AZ

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) terminated its deal with AstraZeneca plc (LSE:AZN; NYSE:AZN) for rights to the pharma's gout drugs Zurampic lesinurad and Duzallo lesinurad/allopurinol.

Ironwood said franchise test markets of the drugs did

Read the full 323 word article

User Sign In